SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Sep-24 7:51 PM View: | Athira Pharma, Inc. (ATHA) | 05-Sep-24 | Sale | 1,272 | $0.57 | $719.95 | (1%) 98.8K to 97.53K | |
05-Sep-24 7:51 PM View: | Athira Pharma, Inc. (ATHA) | 03-Sep-24 | Grant | 5,000 | -- | -- | 5% 93.8K to 98.8K | |
05-Sep-24 7:51 PM View: | Athira Pharma, Inc. (ATHA) | 20-May-24 | Grant | 10,000 | $1.34 | $13,400.00 | 12% 83.8K to 93.8K | |
09-Jun-23 5:06 PM View: | Athira Pharma, Inc. (ATHA) | 07-Jun-23 | Private Purchase | 15,000 | $3.43 | $51,445.00 | 23% 65.01K to 80.01K | |
06-Jun-23 10:00 PM View: | Athira Pharma, Inc. (ATHA) | 05-Jun-23 | Purchase | 45,000 | $3.00 | $135,150.00 | 225% 20.01K to 65.01K | |
06-Jun-23 10:00 PM View: | Athira Pharma, Inc. (ATHA) | 02-Jun-23 | Private Purchase | 20,012 | $2.82 | $56,422.20 | 100% 0 to 20.01K | |
08-Jan-24 4:42 PM View: | Athira Pharma, Inc. (ATHA) | 05-Jan-23 | Sale | 1,208 | $2.91 | $3,515.28 | (1%) 85.01K to 83.8K | |
08-Jan-24 4:42 PM View: | Athira Pharma, Inc. (ATHA) | 04-Jan-23 | Grant | 5,000 | -- | -- | 6% 80.01K to 85.01K | |
13-Feb-17 4:04 PM View: | Immunocellular Therapeutics... (IMUC) | 31-Dec-16 | Payment of Exercise | 3,284 | $2.05 | $6,732.20 | (34%) 9.71K to 6.42K | (15%) |
15-Mar-16 3:55 PM View: | Immunocellular Therapeutics... (IMUC) | 11-Mar-16 | Grant | 150,000 | -- | -- | 63% 238.33K to 388.33K | |
02-Dec-15 7:43 PM View: | Immunocellular Therapeutics... (IMUC) | 30-Nov-15 | Market Purchase | 10,000 | $0.44 | $4,350.00 | 4% 228.33K to 238.33K | (87%) |
24-Mar-15 6:10 PM View: | Immunocellular Therapeutics... (IMUC) | 20-Mar-15 | Grant | 150,000 | -- | -- | 191% 78.33K to 228.33K | |
20-Feb-15 6:36 PM View: | Immunocellular Therapeutics... (IMUC) | 18-Feb-15 | Market Purchase | 41,333 | $0.60 | $24,799.80 | 112% 37.0K to 78.33K | (90%) |
14-Aug-14 5:38 PM View: | Immunocellular Therapeutics... (IMUC) | 14-Aug-14 | Market Purchase | 10,000 | $0.90 | $8,994.00 | 37% 27.0K to 37.0K | (93%) |
18-Dec-13 12:49 PM View: | Immunocellular Therapeutics... (IMUC) | 18-Dec-13 | Market Purchase | 27,000 | $0.72 | $19,361.70 | 100% 0 to 27.0K | (92%) |